Key result
AMI reperfusion and coronary revascularization in dialysis patients lack robust data and yield controversial outcomes.
Why the study?
Despite high cardiac risk in dialysis patients, data on reperfusion therapy outcomes and coronary revascularization remain lacking and controversial.
This review highlights the diagnosis and treatment of coronary artery disease in dialysis patients, noting a lack of data on reperfusion therapy and controversial outcomes for revascularization.
Evidence gaps warrant cautious revascularization decisions in dialysis patients; leaves open the need for dedicated RCTs on AMI reperfusion.
Ischemic heart disease is the major cause of death in dialysis patients. Efforts at coronary artery disease detection in end-stage renal disease patients have primarily focused on the cardiac evaluation of 'high-risk' renal transplant candidates. Despite their high cardiac risk, no data exist on the results of reperfusion therapy in dialysis patients with acute myocardial infarction, and the outcome of coronary revascularization procedures remains controversial. This review highlights recent work on the diagnosis and treatment of coronary artery disease in dialysis patients.
No takes yet. Share an insight, caveat, or question.
Charles A. Herzog (1997) conducted a review in Ischemic heart disease in dialysis patients. Diagnosis and treatment of coronary artery disease was evaluated. A review of ischemic heart disease in dialysis patients reveals a lack of data on reperfusion therapy for acute myocardial infarction and controversial outcomes for coronary revascularization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: